Jeffrey S. Hatfield

Jeffrey S. Hatfield

Independent DirectoratVir Biotechnology· In proxies 2023–2025

Jeffrey S. Hatfield sits on 9 public boards.

Boards1

  • Vir BiotechnologyDirector · 5 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Vir BiotechnologyPublic company · 3 yr
    • Independent Director2023 – Present · 3 yrStock in role -52%
  2. ROME Therapeutics, Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  3. Ambit Biosciences Corp.Public company
    • Director? – PresentNo stock prices for these years
  4. Gate Bioscience, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Larimar Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Viridian TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  7. MiRagen Therapeutics, Inc.Public company · 4 yr
    • Director2017 – 2021 · 4 yrNo stock prices for these years
  8. aTyr Pharma, Inc.Public company · 4 yr
    • Director2017 – 2021 · 4 yrNo stock prices for these years
  9. InVivo Therapeutics, Inc.Public company · 2 yr
    • Director2016 – 2018 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?